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Issues of generation, protection and exploitation of 
intellectual property (IP) are assuming increasing 
importance. The new IP regimes will have wide 
ranging socio-economic, technological and political 
impact. As per the obligations under the Trade-
related Aspects of Intellectual Property Systems 
(TRIPS), all the members of World Trade Organiza-
tion (WTO) are supposed to implement national sys-
tems of intellectual property rights following an 
agreed set of minimum standards. However, there is 
an increasing feeling that harmonization is de-
manded from those that are not equal, either eco-
nomically or institutionally. The major concerns of 
the Third World about such harmonization and the 
new challenge it faces in diverse areas of intellectual 
property protection are discussed and some sugges-
tions about the way ahead are made. 
 The discussion includes the need for a fair play in 
technology transfer, creation of ‘favourable econom-
ics’ of essential medicines from the point of view of 
the  Third World, protection of traditional knowl-
e ge, etc. The creation of Traditional Knowledge 
Digital Library (an essentially Indian initiative) and 
linking it to the International Patent Classification 
System (IPC) through a Traditional Knowledge Re-
source Classification System is an important concep-
tual step forward. The possible models for material 
transfer and benefit sharing when products are cre-
ated based on community knowledge are also dis-
cussed.  
 Other discussions include the challenge of bridging 
the divide between the Third World and other devel-
oped nations, with special emphasis on intellectual 
property information sharing, capacity building with 
creation of appropriate physical and intellectua in-
frastructure and awareness building. It is argued 
that the Third World should negotiate a new ‘TRIPS 
plus’ which means ‘TRIPS plus equity and ethics’. 
 
IPR and Third World concerns  
 
The twenty first century will be the century of knowl-
edge, indeed the century of mind. Innovation is the key 
for the production as well as processing of knowledge. 
A nation’s ability to convert knowledge into wealth and 
social good through the process of innovation will de-
termine its future. In this context, issues of genration, 
valuation, protection and exploitation of intellectual 
property (IP) are going to become critically important 
all around the world. Exponential growth of scientific 
knowledge, increasing demands for new forms of intel-
lectual property protection as well as access to IP re-
lated information, increasing dominance of the new 
knowledge economy over the old ‘brick and mortar’ 
economy, complexities linked to IP in traditional 
knowledge, community knowledge and animate objects, 
will pose a challenge in setting he new 21st century IP 
agenda. Intellectual property will no longer be seen as a 
distinct or self-contained domain, but rather as an im-
portant and effective policy instrument that would be 
relevant to a wide range of socioeconomic, technologi-
cal and political concerns. The development of skills 
and competence to manage IPR and leverage its influ-
ence will need increasing focus; in particular, in the 
Third World. 
 An ideal regime of intellectual property rights strikes 
a balance between private incentives for innovators and 
the public interest of maximizing access to the fruits of 
innovation. This balance is reflected in article 27 of the 
1948 Universal Declaration of Human Rights, which 
r cognizes both that ‘Everyone has the right to the pro- 
tectio  of the moral and material interest resulting from 
any scientific, literacy or artistic production of which he 
is the author’ and that ‘Everyone has the right... to share 
in scientific advancement and its benefits’. The burning 
question seems to be balancing the interest of the inven-
t r and that of the society in an optimum way.  
 I tellectual property rights are being harmonized 
worldwide. As per the obligation under the Trade-
related Aspects of Intellectual Property Systems 
(TRIPS) agreement, developing countries are now im-
plementing national systems of intellectual property 
rights following an agreed set of minimum standards, 
such as twenty years of patent protection; the least de-
ve oped countries have an extra 11 years to do so. One 
of the Third World concerns is that while a fully har-
monized system of IPR is being advocated, today’s ad-
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vanced economies had refused to grant patents through-
out the 19th and early 20th centuries. They formalized 
the enforced intellectual property rights gradually as 
they shifted from being net users of intellectual property 
to being net producers. Indeed, France, Germany and 
Switzerland, who are leading developed countries today 
completed, what is now standard protection, only in the 
1960s and 1970s.  
 Further, there is a feeling that without good advice on 
creating national legislation that makes the most of 
what TRIPS allows, and under pressure to introduce 
legislation beyond that required by TRIPS, many coun-
tries have legislated themselves into a disadvantageous 
position. The TRIPS agreement entered into force in 
most developing countries in January 2000; the least 
developed countries have until 2006. With implementa-
tion still under way and industries still adjusting, little 
empirical evidence is available on the effects of the leg-
islative change. 
 The battle today is between those that are not equal, 
economically and institutionally. TRIPS, like other 
World Trade Organization agreements, is an agreement 
on a legal framework. Its implications will be decided 
by resolving disputes. That makes case law and the 
power of the parties involved of great importance. The 
third world has a clear disadvantage here.  
 In the developing world, the impact of TRIPS will 
vary according to each country’s economic and techno-
logical development. Middle-income countries like 
Brazil and Malaysia are likely to benefit from the spur 
to local innovation. Countries like India and China, 
which are endowed with a large intellectual infrastruc-
ture, can gain in the long term by stronger IPR protec-
tion. However, least developed countries, where formal 
innovation is minimal, are likely to face higher costs 
without the offsetting benefits. 
 TRIPS has important provisions for a fair play in 
technol gy transfer from which the developing world 
should benefit. Article 7 of the TRIPS Agreement states 
‘the protection and enforcement of intellectual property 
rights should contribute to the promotion of technologi-
cal innovation and to the transfer and dissemination of 
technology to the mutual advantage of producers and 
users of technological knowledge and in a manner con-
ducive to social and economic welfare, and to a balance 
of rights and obligations’. Furthermore, Article 8.2 
states ‘appropriate measures, provided they are consis-
tent with the provisions of the Agreement, may be 
needed to prevent the abuse of intellectual property 
rights by right holders or the resort to practices which 
unreasonably restrain trade or adversely affect the  
International transfer of technology’. 
 Facilitating the access of the Third World countries to 
technologies required by them constitutes one of the 
key elements in accelerating the pace of their economic 
and social development. Such access is generally the 
result of licenses and technology transfer agreements. 
The fact of the matter is that the prospective technology 
seekers in developing countries face serious difficulties 
in their commercial dealings with technology h lders in 
the developed countries. These difficulties arise for a 
variety of reasons. Some arise from the imperfections of 
the market for technology. Some are attributed to the 
relative lack of experience and skill of enterprises and 
institutions in developing countries in concluding ade-
quate legal arrangements for the acquisition of technol-
ogy. Some arise due to government practices, both 
legislative and administrative, in both developed and 
d veloping countries, which influence the implementa-
tion of national policies and procedures designed to 
encourage the flow of technology to, and its acquisition 
by, developing countries.  
 There are concrete examples to show that technology 
ransfers to the Third World have not taken place when 
they were needed most. The 1990 Montreal Protocol on 
Subst nces that Deplete the Ozone Layer ran into con-
flicts over commitments to ensure fair and favourable 
access for developing countries to chlorofluorocarbon 
(CFC) substitutes protected by intellectual property 
rights. The 1992 Convention on Biological Diversity 
aims to ensure fair and equitable use of genetic re-
sources partly through technology cperation, but its 
technological provisions have received little atten ion. 
The 1994 TRIPS agreement calls for technology trans-
fer to the least developed countries, yet that provision 
has scarcely been translated into action.  
 The transfer and dissemination needs of the develop-
ing countries have to be seen from the point of view of 
the capacity of those in need of accessing the technolo-
gies, particularly where the cost of technology may be 
prohibitive due to economies of scale and other reasons. 
In such cases, in order to implement the related provi-
sions of the TRIPS Agreement, commercially viable 
mechanisms will have to be found.  
Traditional knowledge protection and 
pr motion 
Let us revisit the process of innovation. Normally when 
we consider innovation, we refer to only formal syste s 
of innovation, namely that done in universities, indus-
trial R&D laboratories, etc. Often not recognized is the 
technology innovation that takes place in an informal 
system of innovation, be it byartisans, farmers, tribes 
or other grassroot innovators. Indeed many societies in 
the Third World have nurtured and refi ed systems of 
knowledge of their own, relating to such diverse do-
mains as geology, ecology, botany, agriculture, physi-
ology and health. These informal innovators have, 
therefore, generated such a rich store of traditional 
knowledge.  
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 One of the concerns of the developing world is that 
the process of globalization is threatening the appro- 
priation of elements of the collective knowledge of so- 
cieties into proprietary knowledge for the commercial 
profit of a few. An urgent action is needed to protect 
these knowledge systems through national policies and 
international understanding linked to IPR, while provid-
ing its development and proper use for the benefit of its 
holders. We need a particular focus on community 
knowledge and community innovation. To encourage 
communities, it is necessary to scout, support, spawn 
and scale up the green grass root innovation. Linking 
innovation, enterprise and investment is particularly 
important. New models and new thinking on IP will 
have to be envisioned to accomplish this.  
 The local communities or individuals do not have the 
knowledge or the means to safeguard their property in a 
system, which has its origin in very different cultural 
values and attitudes. The communities have a store-
house of knowledge about their flora and fauna– their 
habits, their habitats, their seasonal behaviour and the 
like – and it is only logical and in consonance with 
natural justice that they are given a greater say as a mat-
ter of right in all matters regarding the study, extraction 
and commercialization of the biodiversity. A policy that 
does not obstruct the advancement of knowledge, and 
provides for valid and sustainable use and adequate in-
tellectual property protection with just benefit sharing is 
what we need. 
 The issues of the economics of community knowl-
edge are truly complex. While it is true that many in-
digenous cultures appear to develop and transmit 
knowledge from generation to generation within a sys-
tem, individuals in local or indigenous communities can 
distinguish themselves as informal creators or innova-
tors, separate from the community. Furthermore, some 
indigenous or traditional societies are reported to rec-
ognize various types of intellec ual property rights over 
knowledge, which may be held by individuals, families, 
lineages or communities. Discussion of IPRs and tradi-
tional knowledge should draw more on the diversity and 
creativity of indigenous approaches to IPR issues. 
 The existing IPR systems are oriented around the 
concept of private ownership and individual innovation. 
They are at odds with indigenous cultures, which em-
phasize collective creation and ownership of knowl-
edge. There is a concern that IPR systems encourage the 
appropriation of traditional knowledge for commecial 
use, and that too without the fair sharing of benefits of 
the holders of this knowledge. They violate the indige-
nous cultural precepts by encouraging the commodifica-
tion of such knowledge.  
 The issue of ‘protection’ of traditional knowedge 
needs to be looked at from two perspectives, the ‘pro-
tection’ may be granted to xclude the unauthorized use 
by third parties of the protected information. On the 
other hand, the ‘protection’ also means to preserve tra-
ditional knowledge from uses that may erode it or nega-
tively affect the life or culture of the communities that 
have developed and applied it. Further, the protection 
also promotes self-r spect and self-determination. 
 While recognizing the market-based nature of IPRs, 
other non-market-based rights could be useful in devel-
oping models for a right to protect traditional knowl-
edge, innovations and practices. To date, deb  on 
IPRs and biodiversity has focused on patents and plant 
breeders’ rights. Provisions under undisclosed informa-
tion or trade secrets could be invoked to protect tradi-
tional knowledge not available in the public domain. 
Geographical indications and trademarks, or sui generis 
analogies, could also be the al ernative tools for indige-
nous and local communities seeking to gain economic 
benefits from their tradi ional knowledge. The potential 
value of geographical indications and trademarks is in 
pro ecting plants and germplasms that are specific and 
unique to geographical regions. They could protect and 
r ward traditions while allowing innovation. They will 
emphasize the relationships between human cultures 
nd their local land and environment. They are not 
freely transferable from one owner to another. They can 
be maintained as long as the collective tradition is 
maint ined. 
 Giving legally recognized ownership of knowledge to 
communities through sui generis IPRs has several bene-
fits. It will raise the profile of that knowledge and en-
courage respect for it both inside and outside the 
k owledge-holding communities. This will enthuse the 
younger members of such communities to contribute to 
the further development of that knowledge. Further-
more, prospects of economic returns for the use of that 
k owledge by others will act as a further incentive for 
the community memb rs to respect their knowledge and 
continue to engage in practices in that knowledge. Prior 
protection will also provide disclosure, use and prolif-
eration of such knowledge, which might have otherwise 
been eroded.  
 New experiments are beginning to emerge on benefit-
sharing models for indigenous innovation. An experi-
ence in India is worth sharing. It relates to a medicine 
that is based on the active ingredient in a plant, 
Trichopus zeylanicus, found in the tropical forests of 
southwestern India and collected by the Kani tribal 
people. Scientists at the Tropical Botanic Garden and 
R search Institute (TBGRI) in Kerala learned of the 
plant, which is claimed to bolster the immune system 
a  provide additional energy, while on an expedition 
with the Kani in 1987. These scienti ts isolated and 
tested the ingredient and incorporated it into a com-
pound, which they christened ‘Jeevani’, the giver of 
life. The tonic is now being manufactured by a major 
Ayurvedic drug company in Kerala. In 1995, an agree-
ment was struck to share the license fee and 2% of sales
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Trichopus zeylanicus. 
 
 
Box 1. The ‘Jeevani’ and the ‘Kani’ tribes. 
 
The Kani tribals belong to a traditionally nomadic community, who now lead a primarily settled life in the forests of the Agast-
hyamalai hills of the Western Ghats (a mountain range along south-western India) in the Thiruvananthapuram district of Ker-
ala. The Kanis, numbering around 16,000, live in several tribal hamlets, each consisting of 10 to 20 families dispersed in and 
around the forest areas of Thiruvananthapuram district. These Kanis do not constitute a cohesive unit, although they do share 
certain common characteristics and practices. Kanis are the traditional collectors of non-timber forest products from the forest. 
Living close to nature, the Kanis have acquired unique knowledge about the use of the resources, particularly the biological 
resources around them. 
 In December 1987, a team of scientists working on the All India Co-ordinated Research Project on Ethnobiology (AICRPE) 
led by P. Pushpangadan was trekking through the tropical forests of Agasthyar hills. They were surveying the ‘Kani’ tribal set-
tlements and got exhausted after a while. This team was accompanied by a few ‘Kani’ tribesmen as guides, who surprisingly 
remained energetic and agile. They occasionally would munch some small blackish fruits. One of them offered a few of these 
fruits to the team pointing out that if they ate those, they could go on trekking without fatigue. And that is what happened to the 
AICRPE team, after they had followed their advice. It was later that the ‘Kani’ tribesmen introduced the ‘magical’ plant, which 
was subsequently identified as Trichopus zeylanicus ssp. travancoricus. 
 Detailed chemical and pharmacological investigations showed that the leaf of the plant contained various glycolipids and 
some other non-steroidal compounds with profound adaptogenic and immuno-enhancing properties. The fruits showed mainly 
anti-fatigue properties. The Tropical Botanical Garden Research Institute (TBGRI) was successful in developing a scientifically 
validated and standardized herbal drug, based on the tribal lead. The drug was named as ‘Jeevani’ and it was released for 
commercial production in 1995 in Arya Vaidya Pharmacy. While transferring the technology for production of the drug to the 
pharmaceutical firm, TBGRI agreed to share the license fee and royalty with the tribal community on a fifty–fifty basis.  
 The prime concern of the tribals in the beginning was to evolve a viable mechanism for receiving such funds. With the help 
of TBGRI, some government officials and NGOs, the tribals formed a registered trust. About 60% of the Kani families of Kerala 
are members of this trust. From February 1999, the amount due to them has been transferred to this Trust with an understand-
ing that the interest accrued from this amount alone can be used for the welfare activities of the Kani tribe. 
 TBGRI has trained 25 tribal families to cultivate the plant around their dwellings in the forest. In the first year itself, each 
family earned about Rs 8,000 on sale of leaves from cultivation of T. zeylanicus in half-hectare area by each family. But unfor-
tunately the forest department objected to the cultivation with the plea that the tribals may remove the plants from the natural 
population of this species in the forests and thereby make it endangered. It is understood that this problem has now been re-
solved and the Forest department has recently approved the cultivation of this plant. It is significant to note that while the is-
sue of material transfer and benefit sharing was discussed and debated after Convention on Biological Diversity (CBD), India 
has already pioneered one of the first models. 
a 
b 
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of the product as royalty, that was receivabl  by 
TBGRI, will be shared on a fifty–fift  basis with  
the tribe. This marks perhaps the first time that for IP 
held by a tribe, a compensation in the form of cash 
benefits has gone directly to the source of the IP hold-
ers. We are still on the learning curve in this experiment 
(see Box 1) but we need to multiply such examples 
globally. 
IPR and traditional medicine 
Traditional Medicine (TM) plays a crucial role in health-
care and serves the health needs of a vast majority of peo-
ple in developing countries. Access to ‘modern’ health care 
services and medicine may be limited in developing coun-
tries. TM becomes the only affordable treatment available 
to poor people and in remote communities.  
 World Health Organization (WHO) defines tradi-
tional medicine as the sum total of all the knowledge 
and practices, whether explicable or not, used in diag-
nosis, prevention and elimination of physical, mental or 
social imbalance and relying exclusively on practical 
experience and observations handed down from genera-
tion to generation, whether verbally or in writing.
Health care providers worldwide including major phar-
maceutical giants are turning to incorporate many of 
these into their mainstream activities. As traditional 
medicines are largely based on medicinal plants, in-
digenous to these countries, where the system has been 
in vogue for several centuries, the effort is on accessing 
them either directly or through the use of modern tools 
of breeding and cultivation, including tissue culture, 
cell culture and transgenic technology. IP issues linked 
to such endeavours remain unresolved. 
 The protection of TM under intellectual property 
rights (IPRs) raises two types of issues. First, to what 
extent it is feasible to protect, existing IPR system. Cer-
tain aspects of TM may be covered by patents or other 
IPRs. There have also been many proposals to develop 
sui generis ystems of protection. Such proposals are 
based on the logic that if innovators in the ‘formal’ sys-
tem of innovation receive a compensation through IPRs, 
holders of traditional knowledge should be similarly 
treated. 
 
 
Box 2. Re-examination of US patents. 
 
There is a general perception that the process of fighting an erroneous patent is long, arduous and very expensive. This is 
true as exemplified by the Eastman Kodak–Polaroid patent war, which was settled after several years for about a billion dol-
lars. However, the process of re-examination of a US patent, a route that was adopted by CSIR to challenge the turmeric and 
the Basmati patent, is relatively straightforward. It cost CSIR approximately Rs 5 lakhs to win the turmeric case. 
 As per the provision of re-examination of granted US patents, any person may file a request for re-examination of a patent. 
Corporations and/or governmental entities are included within the scope of the term ‘any person’. Even the patent owner can 
ask for a re-examination, which would be limited to an ex-parte consideration of prior patents or printed publications. It is also 
possible for the Commissioner to initiate re-examination at the Commissioner’s own initiative under 37 CFR 1.520. Re-
examination can be initiated by the Commissioner on a very limited basis such as where a general public policy question is at 
issue and there is no interest by ‘any other person’. 
 
The provisions for re-examination are as follows: 
 
1. Anyone can request re-examination at any time during the period of enforceability of the patent. 
2. A substantial new question of patentability must be presented for re-examination to be ordered. 
3. Prior art considered during re-examination is limited to prior art patents or printed publications applied under the appro-
priate parts of 35 U.S.C. 102 and 103. 
4. If ordered, the actual re-examination proceeding is ex-parte in nature. 
5. Decision on the request must be made within three months from initial filing and remainder of proceedings must proceed 
with ‘special dispatch’. 
6. If ordered, a re-examination proceedings will be conducted to conclusion and issuance of certificate. 
7. The scope of a claim cannot be enlarged by amendment. 
8. All re-examination and patent files are open to the public. 
 
After the filing of the re-examination request, the US PTO will decide within three months whether a ‘substantial new question 
of patentability’ has been raised by the request. If so, a decision ordering the re-examination to proceed will be issued. After 
the order to proceed is issued, there is a period of two months during which the patent owner can file a statement or amend-
ment in response to the issues raised in the request. If the patent owner does this, the requester will have a period of two 
months to file a response. This response represents the last opportunity for the requester to participate in the re-examination. 
Ordinarily, the patent owner does not file any paper, so that the only opportunity for the requester to present his views is in the 
initial request papers. Thus, in the case of Turmeric or Basmati, if the full and comprehensive evidence was not presented by 
India, when the initial request was filed, there would have been no opportunity to file further evidence. After the deadline has 
passed for the patent owner to file a statement (or after any statement and response by the requester have been filed), the 
Examiner conducts the re-examination in a manner similar to a regular patent prosecution. The final re-examination certificate 
is then issued, as exemplified in the Turmeric case.  
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Box 3. Turmeric Patent: The chronology and lessons. 
 
Two US-based Indians Suman K. Das and Hari Har P. Cohly were granted a US Patent 5,40,504 on 28 March 1995 on Use of 
turmeric in wound healing. The patent was assigned to University of Mississippi Medical Center, USA. This patent claimed the 
administration of an effective amount of turmeric through local and oral route to enhance the wound healing process, as a 
novel finding. Any patent, before it is granted, has to fulfil the basic requirements of novelty, non-obviousness and utility. Thus, 
if the claims have been covered by relevant published art, then the patent becomes invalid. CSIR could locate 32 references 
(some of them being more than one hundred years old and in Sanskrit, Urdu and Hindi), which showed that this finding was 
well known in India prior to filing of this patent. The formal request for re-examination of the patent was filed by CSIR at 
USPTO on 28 October 1996. 
 The first office action in the re-examination was issued by USPTO on 28 March 1997, which rejected all the six claims based 
on the references submitted by CSIR as being ‘anticipated by the submitted references’ and therefore considered invalid under 
35 U.S.C. 102 and 103. 
 After receiving the first action, the University of Mississippi Medical Centre, to whom the turmeric patent was assigned, de-
cided not to pursue the case and transferred the rights to the inventors, who, however, decided to file a response. The inven-
tors argued that the powder and paste had different physical properties, i.e. bio-availability and absorbability, and therefore, 
one of ordinary skill in the art would not expect, with any reasonable degree of certainty, that a powdered material would be 
useful in the same application as a paste of the same material. The inventors, further, mentioned that oral administration was 
available only with honey and honey itself was considered to have wound healing properties. 
 In the second Office Action, the examiner rejected all the claims once again and made his action final. He made it clear that 
the paste and the powder forms were equivalent for healing wounds in view of the cited art. 
 Subsequent to the second rejection, the inventors had an interview with the examiner and deleted claims 5–6 and also re-
stricted the invention to a ‘non-healing surgical wound’ as supported by the two case histories mentioned in the patent stating 
that there was no disclosure or suggestion of using turmeric in surgically inflicted non-healing wounds and requested the ex-
aminer to allow the amended claims. 
 On 20 November 1997, the examiner rejected all the claims once again as being anticipated and obvious. 
 The re-examination certificate was issued on this case on 21 April 1998 bringing the re-examination proceedings to a close. 
 The following points are interesting to note: 
 
1. The turmeric case was a landmark case in that this was the first time that a patent based on the traditional knowledge of a 
developing country was challenged successfully and USPTO revoked the patent. This eventually opened up the path to the 
creation of Traditional Knowledge Digital Library, Traditional Knowledge Resource Clarification, and finally inclusion of tra-
ditional knowledge in the International Patent Clarification System. 
2. Amidst the loud protests against ‘biopiracy’ and ‘theft’ of India’s biodiversity and traditional knowledge by foreign nationals, 
it is interesting to note here that the patentees were Indians (Das and Cohly), the re-examination in USPTO was done by 
an Indian (Kumar) and the re-examination was sought by an Indian institution (CSIR). 
 
 
 World Intellectual Property Organization (WIPO) has 
been sensitive to these concerns. At a conference h ld 
in October 1998, under the aegis of the WIPO an 
agenda for the future of IPR in the field of traditional 
medicines was prepared, which prioritized activities in 
this area, namely, development of standards for the 
availability, scope and use of IPRs on traditional medi-
cine in Asian countries, systematic documentation of 
traditional medicine for protection purposes, regional 
and inter-regional information exchange and compila-
tion of the requisite databases, etc. This agenda needs to 
be moved forward.  
 The codification of TM varies significantly. A dis-
tinction can be made, particularly in Asia, between the 
codified systems of ‘traditional medicine’ and non-
codified medicinal knowledge, which in ludes ‘folk’, 
‘tribal’ or ‘indigenous’ medicine. Thus, in India, folk 
traditions are handed over orally from generation to 
generation. The ‘folk’ medicine is based on traditional 
beliefs, norms and practices based on centuries old ex-
periences of trials and errors, successes and failures at 
the household level. These are passed through oral tra-
dition and may be called, ‘people’s health culture’, 
home remedies or folk remedies. TM may be possessed 
by individuals. In some cases, for instance, healers use 
rituals as part of their traditional healing methods, 
which often allow them to monopolize their knowledge, 
despite disclosure of the phytochemical products or 
echniques used. The codified tradition consists f 
medical knowledge with sophisticated foundations ex-
pressed in thousands of manuscripts covering all 
branches of medicine. Examples are ayurveda, siddh , 
unani and the Tibetan tradition.  
 The grant of patents on non-original innovations (par-
ticularly those linked to traditional medicines), which 
are based on what is already a part of the traditional 
knowledge of the developing world have been causing a 
great concern to the developing world. It was CSIR that 
challenged the US patent No. 5,401,5041, which was 
granted for the wound healing properties of turmeric. 
The process of re-examination of a US patent is well 
laid out (see Box 2). In a landmark judgement, the US 
Patent Office revoked this patent in 1997, after ascer-
taining that there was no novelty; the findings by inno-
vators having been known in India for centuries (see 
Box 3). 
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 The Coordinating Body of Indigenous Organizations 
of the Amazon Basin (COICA), which represents more 
than 400 indigenous tribes in the Amazon region, along 
with others, protested about a wrong patent (US Plant 
Patent No. 5,751 issued on 1986) that was given on a 
plant species native to the Amazon rainforest, called 
Banisteriopsis caapi and its traditional medicinal uses 
through an indigenous product called ‘Ayahusca’ in 
1999. On reexamination, USPTO revoked this patent on 
3 November 1999. However, the inventor was able to 
convince the USPTO on 17 April 2001, the original 
claims were reconfirmed and the patent rights restored 
to the innovator (see Box 4).  
 These two cases were followed by yet another case of 
revocation in May 2000. The patent granted to W. R. 
Grace Company and US Department of Agriculture on 
Neem (EPO patent No. 436257) by European Patent 
Office was squashed again on the same grounds that its 
use was known in India. India filed a reexamination 
request for the patent on Basmati rice lines and grains 
(US Patent No. 5,663,484) granted by the USPTO, and 
Ricetec Company from Texas has decided to withdraw 
the specific claims challenged by India an also some 
additional claims (see Box 5). 
 There is a problem on the grant of such patents linked 
to the indigenous knowledge of the developing world 
that needs to be addressed jointly by the developing and 
the developed world. We need to understand that there 
is a distinction between the patents that are granted 
based on modern research and patents, which can be 
categorized as traditional knowledge-based patents. A 
recent study by an Indian expert group examined ran-
domly selected 762 US patents, which were granted 
under A61K35/78 and other IPC classes, having a direct 
relationship with medicinal plants in terms of their full 
text. Out of these patents, 374 patents were found to be 
based on traditional knowledge not that all of them were 
wrong. The Governments in the Third World as well as 
members of public are rightly concerned about the grant 
of patents for non-original inventions in the traditional 
knowledge systems of the developing world. At interna-
tional level there is significant level of support for o-
posing the grant of patents on non-original inventions. 
For example, more than a dozen organizations from 
around the world got toge her to oppose the EPO Neem 
patent and the entire process took five years. Such a 
process of opposition is, understandably expensive and 
time consuming. 
 
 
 
Box 4. The case of Amazon Rainforest Plant Patent. 
 
Many traditional healers and religious leaders from the indigenous tribes of the Amazon used to collect a plant named Baniste-
riopsis caapi, and process it to produce a ceremonial drink – ‘ayahausca’, also called ‘yage’. They used ayahausca in religious 
and healing ceremonies. According to tradition, ayahausca was prepared and administered only under the guidance of tradi-
tional healers. A Plant Patent No. 5,751, issued to Loren Miller on 17 June 1986 by USPTO claimed rights over a supposed 
variety of B. caapi, which Miller dubbed ‘Da Vine’. 
 The challenge to this patent was made by the Center for International Environment Law (CIEL), on behalf of the Coordinat-
ing Body of Indigenous Organizations of the Amazon Basin (COICA) and the Coalition for Amazonian Peoples and Their Envi-
ronment (Amazon Coalition). COICA is a coordinating body of more than 400 tribes.  
 It was argued that to obtain a plant patent, an applicant must show that the plant is a new variety; that it is distinct from ex-
isting forms; and that it is now found in an uncultivated state (35 U.S.C. §161). Such patents are authorized under a 1930 law 
designed to reward efforts of growers who develop new varieties of crops such as fruit trees or grapevines. 
 Although the patent claimed to have identified a variety of the species with new and distinctive physical features, particularly 
the colour of the flower. But according to Prof. William A. Anderson of the University of Michigan, a leading expert on the plant 
family to which B. caapi belonged, the features described as ‘prior art’ were already there in the records of major herbaria. 
Further, this plant grew naturally throughout the Amazon basin. By law, plant patents cannot be awarded to plants ‘found in an 
uncultivated state’.  
 The USPTO rejected Miller’s patent claim in an Office Action dated 3 November 1999. The rejection was made on the nar-
rowest grounds possible, under the statutory bar of 35 U.S.C. §102(b). Section 102(b) prohibits, inter alia, the issuance of a 
patent when the invention was patented or described in a printed publication more than one year prior to the date of patent 
application. 
 The rejection notice noted that the accessioned specimen sheets from the Field Museum in Chicago contain specimens of B. 
caapi whose major defining feature is flower colour indistinguishable from that of Da Vine. These sheets were known and 
available in the United States more than one year prior to the filing of Miller’s patent application.  
 By permitting §102(b)’s statutory bar to be met by these specimen sheets, the USPTO confirmed in its rejection that such 
sheets qualify as ‘printed publications’ for the purpose of determining a plant’s patentability. This way the first time the USPTO 
had adopted this interpretation of prior art publications. However, the interpretation is a logical extension of earlier decisions 
that recognized as printed publications single copies of doctoral dissertations catalogued in university libraries, and single cop-
ies of grant proposals indexed and publicly available on file with the National Science Foundation. 
 The case finally took a different turn. The inventor convinced the USPTO about the novelty of his claim to the new variety 
and the USPTO reversed its decision given on 3 November 1999 in the re-examination certificate given by it on 17 April 2001 
with a statement ‘No amendments have been made to the patent. As a result of re-examination, it has been determined that 
the patentability of claim 1 is confirmed’.  
 Thus Turmeric and Basmati still continue to be the only successful battles on traditional knowledge with USPTO todate! 
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 To mitigate this problem, the Indian Goverment has 
taken steps to create a Traditional Knowledge Digital 
Library (TKDL) on traditional medicinal plants and 
systems (see Box 6), which will also lead to a Tradi-
tional Knowledge Resource Classification (TKRC). 
Linking this to internationally accepted International 
Patent Classification (IPC) System will mean building 
the bridge between the knowledge contained in an old 
Sanskrit Shloka and the computer screen of a patent 
examiner in Washington! This will eliminate the prob-
lem of the grant of wrong patents since the Indian rights 
to that knowledge will be known to the examiner. In a 
further action, the examiner has decided to disallow 
seventeen of the twenty claims.  
 Eventually the creation of TKDL in the developing 
world would serve a bigger purpose in providing and 
enhancing its innovation capacity. It could integrate 
widely scattered and distributed references on the tradi-
tional knowledge systems of the developing world in a 
retrievable form. It could act as a bridge between the 
traditional and modern knowledge systems. Availability 
of this knowledge in a retrievable form in many lan-
guages will give a major impetus to modern research in 
the developing world, as it itself can then get involved
in innovative research on adding further value to this 
traditional knowledge; an example being the develop-
ment of an allopathic medicine based on a traditional 
plant-based therapeutic. Sustained efforts on the mod-
ernization of the traditional knowledge systems of the 
developing world will create higher awareness at na-
tional and international level and will establish a scien-
tific approach, that will ensure higher acceptability of 
these systems by practitioners of modern systems and 
public at large.  
IPR and essential medicines for the Third 
World 
The consensus statement of Global Health Forum I, 
February 2000, said ‘The move to globalize the protec-
tion of intellectual property is not politically sustainable 
without, at the same time, making the delivery of health 
t chnology more equitable’. On 23 April 2001 the 
United Nations Commission on Human Rights called on 
governments to ensure the accessibility of pharmaceuti-
cals and medical treatments used to treat pandemics 
such as HIV/AIDS, as well as ‘their affordbility for 
 
 
Box 5. Re-examination of US patent on Basmati. 
 
Background: Rice Tec Inc. had applied for registration of a mark ‘TEXMATI’ before the UK Trade Mark Registry. It was suc-
cessfully opposed by Agricultural and Processed Food Exports Authority (APEDA). One of the documents relied upon by Rice 
Tec as evidence in support of the registration of the said mark was the US Patent 5,663,484 (hereafter referred to as ‘484 pat-
ent) granted by US Patent Office to Rice Tec on 2 September 1997 and that is how this patent became an issue for contest. 
 This US utility patent ‘484, was in a unique way to claim a rice plant having characteristics similar to the traditional Indian 
Basmati Rice lines and with the geographical delimitation covering North, Central or South America or Caribbean Islands. The 
patent was granted to Rice Tec by the US Patent Office on 2 September 1997. The said patent covered 20 claims covering not 
only a novel rice plant but also various rice lines; resulting plants and grains, seed deposit claims, method for selecting a rice 
plant for breeding and propagation. Its claims 15–17 were for a rice grain having characteristics similar to those from Indian 
Basmati rice lines. The said claims 15–17 would have come in the way of Indian exports to US, if legally enforced. The grant 
of this patent created a stir in the public, government, business circles and academics.  
 In the wake of this controversy, the Government of India set up a Task Force under the Chairmanship of Secretary, Ministry 
of Industrial Development, to examine the possibilities of filing a re-examination request against the above-mentioned US Pat-
ent. The Task Force, in turn, set up a Technical Committee comprising primarily the ICAR and CSIR scientists to examine the 
Patent specification in detail and to collect necessary documentary evidence that may be required to file the re-examination 
request against the US Patent.  
 Evidence from the IARI Bulletin was used against claims 15–17. The evidence was backed up by the germplasm collection 
of Directorate of Rice Research, Hyderabad since 1978. The various grain characteristics were evaluated by CFTRI scientists 
and accordingly the claims 15–17 were attacked on the basis of the declarations submitted by CFTRI scientists on grain char-
acteristics. 
 Eventually, a request for re-examination of this patent was filed on 28 April 2000. Soon after filling the re-examination re-
quest, Rice Tec chose to withdraw claims 15 to 17 along with claim 4. 
 Although Rice Tec did withdraw these claims, the US Patent Office on its own judged that ‘a substantial question of pat-
entability has been raised in respect of the remaining claims’.  
 Based on the exhaustive office action, Rice Tec has now surrendered the claims 1 to 3, 5 to 7, 10, 14 and 18 to 20.  
 As such, the claims that Rice Tec now intends to protect are 8, 9, 11, 12 and 13. These claims pertain to specific rice lines 
and the progeny and the grains of the specific crosses. This means that as against the Indian attack on 3 claims, Rice Tec is 
withdrawing 15 claims.  
 In summary, Rice Tec having withdrawn claims 15–17, the threat of infringement by the export of Basmati grains to US has 
been averted. And now, with the surrender of all the other broad claims, even the alleged threat to the export of grains of in-
sensitive rice lines from India has been averted. Further, USPTO has ordered that the title of the patent be changed from 
‘Basmati Rice Lines and Grains’ to ‘Rice Lines Bas867, RT1117 and RT1121’. In short, the objective for which India had filed 
the re-examination case has been fulfilled.  
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Box 6. Traditional Knowledge Digital Library. 
 
Three issues relating to treating traditional knowledge ‘on par’ with industrial property systems, designing new International 
Patent Classification Systems to give due recognition to traditional knowledge, and creating a Traditional Knowledge Digital 
Library (TKDL) were taken up by this author with World Intellectual Property Organization (WIPO), when he was the Chairman 
of the Standing Committee on Information Technology (SCIT) in WIPO during 1998–99. This had found a generally favourable 
response from the member states.  
 A comprehensive initiative was spearheaded by the Department of Indian Systems of Medicine and Homeopathy (ISMH). It 
set up an inter-disciplinary task force, known as TKDL task force, by drawing experts from Central Council of Research of  
Ayurveda and Siddha, Banaras Hindu University, National Informatics Centre, Council of Scientific & Industrial Research and 
Controller General of Patents and Trade Marks.  
 The Task Force evolved a scientific classification approach known as Traditional Knowledge Resource Classification 
(TKRC), which would enable retrieval of information on traditional knowledge in a scientific and rational manner. The structure 
of TKRC would be similar to that commonly used for classifying modern innovations, which enable an easy linkage with the  
International Patent Classification (IPC). All the patent examiners around the world use IPC during patent examination.  
 Early this year, WIPO set up a Traditional Knowledge Task Force consisting of US, Japan, European Union, China and  
India. The Indian proposal on creating TKRC was presented to them. All members of the Task Force (significantly, including 
China, which has a rich traditional knowledge of its own) fully endorsed the Indian effort. The Task Force has already initiated 
its work and is likely to submit the draft report to WIPO by February 2002. 
 If this report is accepted, then what would be its effect? First, IPC has more than one hundred thousand sub-groups for re-
trieving information on modern scientific inventions. However, it has only one sub-group for retrieving information on medicinal 
plants. Indian TKRC has information on 5,000 sub-groups. Therefore, their inclusion in IPC will enhance the quality of patent 
examination substantially. Secondly, similar systems will be evolved by other countries and regions, such as China, Latin 
America, Indonesia, etc. which are rich in traditional knowledge. Traditional knowledge of the developing world will thus get a 
legitimacy. The burning issue of the grant of wrong patents based on the traditional knowledge of the Third World will also be 
resolved to a large extent, since the patent examiners will have access to the pertinent information in an appropriately classi-
fied form.  
 
 
all’, in accordance with international law and interna-
tional agreements. The resolution also calls on govern-
ments ‘to safeguard access to such preventive, curative 
or palliative pharmaceuticals or medical technologies 
from any limitations by third parties’. However, the 
recent landmark event on medicines HIV/AIDS in South 
Africa has raised new questions in this regard. 
 The adoption of the TRIPS Agreement has entailed 
significant changes for the protection of pharmaceuti al 
products and processes. The Agreement not only made 
product patent protection binding to all Member coun-
tries (article 27.1); it also strengthened, inter alia, proc-
ess patents (articles 28(b) and 34), narrowly defined the 
conditions for establishing exceptions to patent rights 
(article 30), and limited the possibility of applying es-
pecial modalities of compulsory licenses to pharmaceu-
ticals (e.g. as provided for in Canada until 1993). 
 A key question is whether the TRIPS regime has led 
to an increase in the prices of patented medicines. Al-
though many researchers argue that that there is no clear 
relationship between the patents and the prices of med-
cines, there is a strong evidence that aver ge pharm-
ceutical product prices decline in the face of entry by 
generic substitutes. Competition is important to keep 
prices down.  
 There are a number of options available within 
TRIPS to ensure affordable access. Compulsory licens-
ing, parallel imports and differential pricing between 
developed and developing countries have been sug-
gested as instruments to improve access within the 
broad framework of TRIPS. But it is not clear as to the 
kind of legal instrument that could be used to enforce 
differential pricing and segment markets. It is also not 
clear as to whether TRIPS regime is compatible with 
national exhaustion or international exhaustion. There is 
an additional problem with differential pricing in those 
developing countries, which have capacity for produc-
ing generics. They will slap on anti-dumping duties be-
c use of the pressure from domestic industry. Under the 
differential pricing re ime, one will have to decide as to 
how to organize competition based on ngotiated prices. 
There is also a fear that if one segments markets in 
pharmaceuticals in this manner, these will have repur-
cussions in other sectors.  
 The full implementation and application of the TRIPS 
A reement will entail welfare losses to varying extent 
depending on the economic status of individual coun-
tries. The question is about the extent of this loss and what 
shoul be done to mitigate the adverse consequences. 
Bridging the divide  
International agencies will have to make an effort to 
bridge the gap between the developed world and the 
Third World. Some laudable efforts are afoot in this 
direction. WIPO is setting up WIPONET to narrow the 
information access gap that exists between the devel-
oped countries and developing countries; improve the 
flow of information concerning intellectual property 
rig ts among WIPO member states, regional intellectual 
property offices and the International Bureau; to im-
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prove access to and exchange of intellectual property 
information in terms of costs and access time; to im-
prove intellectual property information disseminat on; 
to consider the information needs and filing require-
ments of applicants and develop electroni  services 
keeping in mind the need to provide benefits to appl-
cants and intellectual property offices, and to other 
interested parties; to help guide the International Bureau 
to leverage information technologies and to improve the 
retrieval of intellectual property information through 
further development of international classification  of 
patents, trademarks and industrial designs as efficient 
search tools.  
 Inadequate preparedness of many national IP offices 
in most of the developing countries is a srious concern. 
The problem areas pertain to manual and paper-based 
operations, static manpower resources, rapid incre se in 
the number of applications filed in recent years leading 
to inordinate delays in granting IPRs, non-uniformity in 
the examination, poor quality of search resulting in 
fresh objections even after the first examination report, 
inadequate search facilities and tools and lack of digital 
data & networks. Most seriously, IT has not yet been 
inducted in the IP administration in most cases. The 
question of capacity of the Third World IP Offices to 
handle complex IP issues is a seriou  one. In the year 
2000, the World Intellectual Property Organization re-
ceived 30 patent applications, which were over 1,000 
pages long, with several reaching 140,00 pages. It is 
clear that the patent offices in the developing countries 
may not even have a capacity to handle t is.  
 The Third World faces several other challenges. 
Weak physical infrastructure in terms of inadequate IP 
offices, as explained above, is just one aspect; but in-
adequate intellectual infrastructure, poor public aware-
ness and lack of government policies that are not in tune 
with the times are some other hurdles. Many R&D insti-
tutions and industrial firms in the developing world 
have so far focussed on imitative research or reverse 
engineering, and have depended heavily on borrowed 
technology and, therefore, not created productive na-
tional IP portfolio. Apart from manpower planning for 
IPR protection setting up of patent training institutes 
and specialized courses, a judicious management of 
patent information is the need of the hour. This will 
require well-structured functioning of information  
creating centres, information documenters and retriev-
ers, information users and information technology ex-
perts. 
 Internet can play a key role in the protection and 
promotion of traditional knowledge of the communities 
(while bringing in added economic value to these com-
munities). An example is the recent exp riment in India 
of the design of an e-commerce portal for Indian 
craftsmen and artisans, which will link individual 
craftsmen directly to designers and markets. It will be
p ssible through this portal for a garment buyer in any 
part of the world to approach any craftsman directly, 
select a pattern, a weave and a fabric and place his order 
with him. This will mean not only a multiple increase in 
the craftsman’s income but also his direct interaction 
with the market. This will unleash the creative skills to 
meet the demands of his market, and further enhance 
the innovation capacity. New challenges in IP protec-
tion will emerge as internet becomes a major fcilitator 
in commercialization of traditional knowledge.  
Finally 
The industrial property systems were set up centuries
ago for inanimate objects and that too in formal systems 
of innovation. The time has come to revisit them. The 
emerging challenge is to look at the systems that will 
deal with animate objects (such as plants and animals) 
and with informal systems innovation (such as those by 
grass root innovators like farmers, artisans, tribes, fish-
ermen and so on). The standard intellectual property 
systems will certainly not suit such innovators and their 
i novations. We, therefore, need innovation in the intel-
lectual property system itself! The issue of whether 
TRIPS should fundamentally beong to WTO is under 
discussion. Other issues such as the desirability of uni-
f rmity of patent term, need for new reforms to exclude 
certain sectors from TRIPS, lowering the minimum 
standards, differential treatment depending the state of 
economy of a developing country, etc. are also under 
discussion.  
 Finally, it is important is to rec gnize that the princi-
p l objective of the GATT/WTO system is to prom te 
free trade. This can be done if competitive opportunities 
are p ovided across the nations on a non-discriminatory 
basis. The TRIPS provisions should be interpreted. In 
other words, the emphasis should be on promotion of 
competition, and not its restriction. The TRIPS provi-
sions have to be interpr ted in this context alone, and 
especially with an aim of laying down the foundation of 
a fair trade system. It is hoped that the Third World 
concerns enumerated in this paper will be addressed by 
a dialogue to create a new ‘TRIPS plus’, getting a new 
meaning of ‘TRIPS plus equity and ethics’. 
Glossary 
Convention on Biodiversity (CBD): The convention 
was opened at the United Nations Conference on E vi-
ronment and Development in Rio de Janeiro in June 
1992. It came into force at the end of 1993 and has now 
been ratified by the overwhelming majority of coun-
tries, for whom it is now a legally binding commitment 
to conserve biological diversity, to sus ainably use its 
components and to share equitably the benefits arising 
from the use of genetic resources. 
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Compulsory licensing: If the reasonable requirements 
of the public with respect to the patented invention have 
not been satisfied or if the patented invention is not 
available to the public at a reasonable price, then a 
prayer for the grant of a compulsory license to work the 
patented invention can be made. This is done at any 
time after the expiry of a three years period from the 
date of the grant of a patent. 
 
General Agreement on Tariffs and Trade (GATT): 
GATT, the organization which was established in 1947 
as the organization overseeing the multilateral trade 
system has been replaced by WTO with effect from 1 
January 1995. 
 
International Patent Classification (IPC): IPC subdi-
vides the whole gamut of technology into different sub-
groups and is used by the national patent offic s 
throughout the world in classifying the subject matter 
contained in patent documents. Each patent document 
bears one or more IPC codes assigned to it by the re-
spective Patent Office. 
 
Parallel Import: Parallel imports involve the import 
and resale in a country, without the consent of the pat-
ent holder, of a patented product which was put on the 
market of the exporting country by the title holder or in 
another legitimate manner. 
 
Agreement on Trade-Related Aspects of Intellectual 
Property Rights (TRIPS 1994): This Agreement con-
stitutes Annex IC of the Marrakesh Agreement Estab-
lishing the World Trade Organization, which was 
concluded on 15 April 1994, and entered into force on 1 
Ja uary 1995. The TRIPS Agreement binds all Mem-
bers of the WTO. 
 
Traditional Knowledge Digital Library (TKDL): An 
Indian initiative, presently aims at documenting and 
classifying according to IPC, knowledge from tradi-
tional systems such as Ayurveda, Unani and Siddha. 
 
Traditional Knowledge Resource Classification 
(TKRC): TKRC is the classification evolved to enable 
etrieval of information on traditional knowledge in  
a scientific manner so that it can be readily linked to 
IPC. 
 
World Intellectual Property Organization (WIPO): 
WIPO is an international organization dedicated to 
promoting the use and protection of works of human 
intellect and is one of the sixteen specialized agencies 
f th  United Nations System of organization. Pres-
ently, 177 nations are its members. 
 
WIPONET: WIPONET is a global Intellectual Prop-
erty network set up by WIPO enabling the integration of 
IP information resources, processes and systems of 
w rld wide Intellectual Property communities, particu-
la ly IP offices of the member states. 
 
World Trade Organization (WTO): WTO is the only 
global international organization dealing with the rules 
of trade between nations. WTO come into being on 1 
January 1995. As one of the youngest international or-
ganizations, it is a successor to GATT.
 
 
 
